1 Video
1st Conference
15 Videos
New Horizons in Drug Discovery for Rare Diseases - The First BCDD Conference, Sep. 8th, 2016
All Rights Reserved
Miguel Weil - Conference organizer, Yoav Henis - TAU Vice President for Research and Development, Ehud Gazit - BCDD Academic Director. The First BCDD Conference -New Horizons in Drug Discovery for Rare Diseases, Blavatnik Center for Drug Discovery, Tel Aviv University, 8.9.2016.
More videos
Phosphatidylserine ameliorates neurodegenerative symptoms and enhances axonal....
ALS: Macrophage Migration Inhibitory Factor Reduced Misfolded SOD1 Accumulation and Toxicity...
Testing the mechanical model of human laminopathies
Inhibition of nonsense mediated mRNA decay to improve stop codon read-through therapy
Small molecule ER stress inhibitors for Huntington’s disease
The use of patient's fibroblasts for the evaluation of small molecules on mitochondrial diseases
Combining High Throughput Screening with Image-Based Phenotyping advances drug discovery
Metabolite amyloids: a new paradigm for inborn error of metabolism disorders
Novel approach for personalized medicine of rare diseases
Restoration of CFTR function by Antisense Oligonucleotide splicing modulation
Drug discovery for rare diseases- bridging the gap between academia and industry
Merging a comprehensive preconception carrier screening panel and chromosomal microarray analysis
Advances in genetics: what are the benefits for patients?
"ADI" Association Duchenne Israel
Introductory Remarks
